213 related articles for article (PubMed ID: 36082464)
1. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
[TBL] [Abstract][Full Text] [Related]
2. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of essential meiotic endonuclease 1 to prognosis and immune infiltration in kidney renal clear cell carcinoma.
Li HD; Ma HX; Ma JH; Kong SP; Zhao ST; Fan SQ; Qin F; Ma JG
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):584-602. PubMed ID: 38305603
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
Front Immunol; 2022; 13():926461. PubMed ID: 36311770
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Chen N
Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
[TBL] [Abstract][Full Text] [Related]
6. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract][Full Text] [Related]
7. Low
Xie Z; Chen N
Transl Cancer Res; 2023 Nov; 12(11):3045-3060. PubMed ID: 38130311
[TBL] [Abstract][Full Text] [Related]
8. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
9. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Zou X; Mo Z
Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
[TBL] [Abstract][Full Text] [Related]
10. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration.
Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G
Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
[No Abstract] [Full Text] [Related]
13. MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53.
Yang Y; Luo Y; Huang S; Tao Y; Li C; Wang C
Cancer Biomark; 2023; 36(4):267-278. PubMed ID: 36938725
[TBL] [Abstract][Full Text] [Related]
14. [Expression and Clinical Significance of Late Endosomal/Lysosomal Adaptor,Mitogen-activated Protein Kinase and Mammalian Target of Rapamycin Activator 3 in Bladder Carcinoma].
Deng LH; Xu FH; Zeng T; Xu XD; Chao HC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):601-608. PubMed ID: 31699189
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of PTEN-related ceRNA network revealing the key pathways WDFY3-AS2 - miR-21-5p/miR-221-3p/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Zhou X; Liu G; Xu M; Ying X; Li B; Cao F; Cheng S; Xiao B; Cheng M; Liang L; Jia M; Li W; Liu J; Li Z
Mol Carcinog; 2022 May; 61(5):508-523. PubMed ID: 35129856
[TBL] [Abstract][Full Text] [Related]
16. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
Cheng L; Mi J; Zhang J; Huang H; Mo Z
Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
[TBL] [Abstract][Full Text] [Related]
17. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
[TBL] [Abstract][Full Text] [Related]
18. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma.
Ding J; Zhao S; Chen X; Luo C; Peng J; Zhu J; Shen Y; Luo Z; Chen J
Front Genet; 2022; 13():835355. PubMed ID: 35480320
[No Abstract] [Full Text] [Related]
20. Comprehensive analysis of
Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
[No Abstract] [Full Text] [Related]
[Next] [New Search]